Reducing risk of disabling stroke with ticagrelor after an ischemic stroke

Takeaway

  • Compared with aspirin alone, the addition of ticagrelor significantly reduced the 30-day risk of disabling stroke or death in patients who had a noncardioembolic acute ischemic stroke.

Why this matters

  • Disability 3 months after stroke onset has been reported to be an independent predictor of future death. Disability after a transient ischemic attack (TIA) or ischemic stroke may be caused by damage from the index stroke or a subsequent stroke.

  • Reducing subsequent disabling stroke is the main goal of preventative treatment in the acute setting after TIA or ischemic stroke.

  • Ticagrelor was able to prevent disabling stroke or death at 30 days and reduce the total burden of disability in patients with TIA or minor ischemic stroke, thus may be a useful therapy for improving long-term outcomes following TIA or ischemic stroke.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.